Halozyme Therapeutics reported $216.59M in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Amarin AMRN:US $ -13.15M 20.96M
Amgen AMGN:US $ 1884M 1420M
Aptinyx Inc APTX:US $ -21231000 1.41M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
Baxter International BAX:US $ 450M 152M
Cytokinetics CYTK:US $ -76.09M 14.53M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Halozyme Therapeutics HALO:US $ 216.59M 125.13M
Immunogen IMGN:US $ -37.34M 6.6M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Intra Cellular Therapies ITCI:US $ -76.91M 8.16M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
JAZZ PHA JAZZ:US $ -52.83M 310.48M
Mannkind MNKD:US $ -4.43M 31.1M
Minerva Neurosciences NERV:US $ -9.2M 1.38M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Peregrine Pharmaceuticals PPHM:US $ 6.3M 4.31M
Pfizer PFE:US $ 8146M 2582M
Rigel Pharmaceuticals RIGL:US $ -20.95M 7.13M
United Therapeutics UTHR:US $ 162.7M 9.9M
Vanda Pharmaceuticals VNDA:US $ 7.77M 1.88M